Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,191 | 2,892 | 5,571 | 8,920 | 4,706 |
| Other current assets | 0 | 0 | 0 | 22 | 0 |
| TOTAL | $1,879 | $4,838 | $7,478 | $9,800 | $5,633 |
| Non-Current Assets | |||||
| PPE Net | 5 | 5 | 2 | 2 | 3 |
| Other Non-Current Assets | 1,345 | 99 | 121 | 142 | 152 |
| TOTAL | $1,350 | $104 | $123 | $144 | $154 |
| Total Assets | $3,229 | $4,942 | $7,601 | $9,945 | $5,787 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 881 | 712 | 953 | 455 | 312 |
| Accrued Expenses | 579 | 413 | 505 | 466 | 146 |
| Other current liabilities | N/A | N/A | N/A | N/A | 189 |
| TOTAL | $1,533 | $1,219 | $1,552 | $1,011 | $731 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1 | 2 | 26 | 51 | 67 |
| TOTAL | $1 | $2 | $26 | $51 | $67 |
| Total Liabilities | $1,533 | $1,221 | $1,577 | $1,061 | $798 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 211 | 131 | 130 | 114 | 114 |
| Retained earnings | -87,219 | -84,491 | -81,106 | -78,096 | -75,369 |
| Other shareholders' equity | -300 | -300 | -300 | -300 | -300 |
| TOTAL | $1,696 | $3,721 | $6,024 | $8,883 | $4,989 |
| Total Liabilities And Equity | $3,229 | $4,942 | $7,601 | $9,945 | $5,787 |